441 related articles for article (PubMed ID: 18850474)
61. Remodeling associated expression of matrix metalloproteinase 9 but not tissue inhibitor of metalloproteinase 1 in airway epithelium: modulation by immunostimulatory DNA.
Cho JY; Miller M; McElwain K; McElwain S; Shim JY; Raz E; Broide DH
J Allergy Clin Immunol; 2006 Mar; 117(3):618-25. PubMed ID: 16522462
[TBL] [Abstract][Full Text] [Related]
62. Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis.
Jordán A; Roldán V; García M; Monmeneu J; de Burgos FG; Lip GY; Marín F
J Intern Med; 2007 Sep; 262(3):385-92. PubMed ID: 17697160
[TBL] [Abstract][Full Text] [Related]
63. Expression of matrix metalloproteinase-2 and -9 and of tissue inhibitor of matrix metalloproteinase-1 in liver regeneration from oval cells in rat.
Pham Van T; Couchie D; Martin-Garcia N; Laperche Y; Zafrani ES; Mavier P
Matrix Biol; 2008 Oct; 27(8):674-81. PubMed ID: 18678246
[TBL] [Abstract][Full Text] [Related]
64. Metalloproteinase function in chronic rhinosinusitis with nasal polyposis.
Kostamo K; Tervahartiala T; Sorsa T; Richardson M; Toskala E
Laryngoscope; 2007 Apr; 117(4):638-43. PubMed ID: 17429873
[TBL] [Abstract][Full Text] [Related]
65. [Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in the urine of children with pyelonephritis].
Tenderenda E; Zoch-Zwierz W; Wasilewska A; Porowski T; Taranta-Janusz K; Kołodziejczyk Z; Michaluk-Skutnik J
Pol Merkur Lekarski; 2009 Jul; 27(157):10-3. PubMed ID: 19650421
[TBL] [Abstract][Full Text] [Related]
66. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.
Tan J; Hua Q; Xing X; Wen J; Liu R; Yang Z
Hypertens Res; 2007 Oct; 30(10):959-63. PubMed ID: 18049028
[TBL] [Abstract][Full Text] [Related]
67. The expression of MMP-2, MMP-7, MMP-9, and TIMP-1 in chronic rhinosinusitis and nasal polyposis.
Can IH; Ceylan K; Caydere M; Samim EE; Ustun H; Karasoy DS
Otolaryngol Head Neck Surg; 2008 Aug; 139(2):211-5. PubMed ID: 18656717
[TBL] [Abstract][Full Text] [Related]
68. Upregulation of tissue inhibitor of metalloproteases-1 (TIMP-1) and procollagen-N-peptidase in hypertension-induced renal damage.
Hultström M; Leh S; Skogstrand T; Iversen BM
Nephrol Dial Transplant; 2008 Mar; 23(3):896-903. PubMed ID: 17977875
[TBL] [Abstract][Full Text] [Related]
69. Indices of extracellular matrix turnover in human masseter muscles as markers of craniofacial form--a preliminary study.
Tippett HL; Dodgson LK; Hunt NP; Lewis MP
Eur J Orthod; 2008 Apr; 30(2):217-25. PubMed ID: 18263891
[TBL] [Abstract][Full Text] [Related]
70. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
[TBL] [Abstract][Full Text] [Related]
71. Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer.
Iniesta P; Morán A; De Juan C; Gómez A; Hernando F; García-Aranda C; Frías C; Díaz-López A; Rodríguez-Jiménez FJ; Balibrea JL; Benito M
Oncol Rep; 2007 Jan; 17(1):217-23. PubMed ID: 17143501
[TBL] [Abstract][Full Text] [Related]
72. [Expression of matrix metalloproteinases-9 and tissue inhibitors of matrix metalloproteinases-1 in connective tissue of vaginal wall of women with stress urinary incontinence].
Zhang QF; Song YF; Zhu ZY
Zhonghua Fu Chan Ke Za Zhi; 2006 Dec; 41(12):810-3. PubMed ID: 17327109
[TBL] [Abstract][Full Text] [Related]
73. Increased matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 secretion but unaffected invasiveness of endometrial stromal cells in adenomyosis.
Yang JH; Wu MY; Chen MJ; Chen SU; Yang YS; Ho HN
Fertil Steril; 2009 May; 91(5 Suppl):2193-8. PubMed ID: 18692810
[TBL] [Abstract][Full Text] [Related]
74. Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis.
Collette T; Maheux R; Mailloux J; Akoum A
Hum Reprod; 2006 Dec; 21(12):3059-67. PubMed ID: 16880228
[TBL] [Abstract][Full Text] [Related]
75. Quantitative analysis of messenger RNA expression of matrix metalloproteinases (MMP-2 and MMP-9), tissue inhibitor-2 of matrix metalloproteinases (TIMP-2), and steroidogenic enzymes in bovine placentomes during gestation and postpartum.
Takagi M; Yamamoto D; Ohtani M; Miyamoto A
Mol Reprod Dev; 2007 Jul; 74(7):801-7. PubMed ID: 17154296
[TBL] [Abstract][Full Text] [Related]
76. Alterations in peripheral blood levels of TIMP-1, MMP-2, and MMP-9 in patients with type-2 diabetes.
Lee SW; Song KE; Shin DS; Ahn SM; Ha ES; Kim DJ; Nam MS; Lee KW
Diabetes Res Clin Pract; 2005 Aug; 69(2):175-9. PubMed ID: 16005367
[TBL] [Abstract][Full Text] [Related]
77. Synovial membrane expression of matrix metalloproteinases and tissue inhibitor 1 in juvenile idiopathic arthritides.
Gattorno M; Gerloni V; Morando A; Comanducci F; Buoncompagni A; Picco P; Fantini F; Pistoia V; Gambini C
J Rheumatol; 2002 Aug; 29(8):1774-9. PubMed ID: 12180743
[TBL] [Abstract][Full Text] [Related]
78. Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression.
Hornebeck W; Lambert E; Petitfrère E; Bernard P
Biochimie; 2005; 87(3-4):377-83. PubMed ID: 15781325
[TBL] [Abstract][Full Text] [Related]
79. Latent MMP-9 is bound to TIMP-1 before secretion.
Roderfeld M; Graf J; Giese B; Salguero-Palacios R; Tschuschner A; Müller-Newen G; Roeb E
Biol Chem; 2007 Nov; 388(11):1227-34. PubMed ID: 17976016
[TBL] [Abstract][Full Text] [Related]
80. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]